Correlation Between Emergent Biosolutions and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Solid Biosciences LLC, you can compare the effects of market volatilities on Emergent Biosolutions and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Solid Biosciences.
Diversification Opportunities for Emergent Biosolutions and Solid Biosciences
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Emergent and Solid is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Solid Biosciences go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Solid Biosciences
Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Solid Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Emergent Biosolutions is 1.67 times less risky than Solid Biosciences. The stock trades about -0.23 of its potential returns per unit of risk. The Solid Biosciences LLC is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 407.00 in Solid Biosciences LLC on December 29, 2024 and sell it today you would earn a total of 25.00 from holding Solid Biosciences LLC or generate 6.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Emergent Biosolutions vs. Solid Biosciences LLC
Performance |
Timeline |
Emergent Biosolutions |
Solid Biosciences LLC |
Emergent Biosolutions and Solid Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Emergent Biosolutions and Solid Biosciences
The main advantage of trading using opposite Emergent Biosolutions and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |